| [1] | Eskenazi B, Warner ML (1997) Epidemiology of endometriosis. Obstetrics and gynecology clinics of North America 24: 235–258. pmid:9163765 doi: 10.1016/s0889-8545(05)70302-8
|
| [2] | Villa ML (1994) Endometriosis. The New England journal of medicine 330: 70. doi: 10.1056/nejm199401063300120
|
| [3] | Csapo AI, Pulkkinen M (1978) Indispensability of the human corpus luteum in the maintenance of early pregnancy. Luteectomy evidence. Obstetrical & gynecological survey 33: 69–81. doi: 10.1097/00006254-197802000-00001
|
| [4] | Prapas Y, Prapas N, Jones EE, Duleba AJ, Olive DL, et al. (1998) The window for embryo transfer in oocyte donation cycles depends on the duration of progesterone therapy. Hum Reprod 13: 720–723. pmid:9572441 doi: 10.1093/humrep/13.3.720
|
| [5] | Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, et al. (1995) Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 9: 2266–2278. pmid:7557380 doi: 10.1101/gad.9.18.2266
|
| [6] | Martin L, Finn CA, Trinder G (1973) Hypertrophy and hyperplasia in the mouse uterus after oestrogen treatment: an autoradiographic study. J Endocrinol 56: 133–144. pmid:4683406 doi: 10.1677/joe.0.0560133
|
| [7] | Huet-Hudson YM, Andrews GK, Dey SK (1989) Cell type-specific localization of c-myc protein in the mouse uterus: modulation by steroid hormones and analysis of the periimplantation period. Endocrinology 125: 1683–1690. pmid:2667965 doi: 10.1210/endo-125-3-1683
|
| [8] | Martin L, Das RM, Finn CA (1973) The inhibition by progesterone of uterine epithelial proliferation in the mouse. J Endocrinol 57: 549–554. pmid:4715727 doi: 10.1677/joe.0.0570549
|
| [9] | Paria BC, Huet-Hudson YM, Dey SK (1993) Blastocyst's state of activity determines the "window" of implantation in the receptive mouse uterus. Proc Natl Acad Sci U S A 90: 10159–10162. pmid:8234270 doi: 10.1073/pnas.90.21.10159
|
| [10] | Clarke CL, Sutherland RL (1990) Progestin regulation of cellular proliferation. Endocr Rev 11: 266–301. pmid:2114281 doi: 10.1210/edrv-11-2-266
|
| [11] | Franco HL, Rubel CA, Large MJ, Wetendorf M, Fernandez-Valdivia R, et al. (2012) Epithelial progesterone receptor exhibits pleiotropic roles in uterine development and function. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 26: 1218–1227. doi: 10.1096/fj.11-193334
|
| [12] | Tan J, Paria BC, Dey SK, Das SK (1999) Differential uterine expression of estrogen and progesterone receptors correlates with uterine preparation for implantation and decidualization in the mouse. Endocrinology 140: 5310–5321. pmid:10537162 doi: 10.1210/en.140.11.5310
|
| [13] | Kaunitz AM (1998) Injectable depot medroxyprogesterone acetate contraception: an update for U.S. clinicians. Int J Fertil Womens Med 43: 73–83. pmid:9609206
|
| [14] | Olive DL, Lindheim SR, Pritts EA (2004) New medical treatments for endometriosis. Best Pract Res Clin Obstet Gynaecol 18: 319–328. pmid:15157645 doi: 10.1016/j.bpobgyn.2004.03.005
|
| [15] | Bulun SE, Cheng YH, Yin P, Imir G, Utsunomiya H, et al. (2006) Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol 248: 94–103. pmid:16406281 doi: 10.1016/j.mce.2005.11.041
|
| [16] | Kao LC, Germeyer A, Tulac S, Lobo S, Yang JP, et al. (2003) Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 144: 2870–2881. pmid:12810542 doi: 10.1210/en.2003-0043
|
| [17] | Burney RO, Talbi S, Hamilton AE, Vo KC, Nyegaard M, et al. (2007) Gene Expression Analysis of Endometrium Reveals Progesterone Resistance and Candidate Susceptibility Genes in Women with Endometriosis. Endocrinology. doi: 10.1210/en.2006-1692
|
| [18] | Jick SS (1993) Combined estrogen and progesterone use and endometrial cancer. Epidemiology 4: 384. pmid:8347751 doi: 10.1097/00001648-199307000-00016
|
| [19] | Ehrlich CE, Young PC, Stehman FB, Sutton GP, Alford WM (1988) Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium. Am J Obstet Gynecol 158: 796–807. pmid:2966586 doi: 10.1016/0002-9378(88)90075-0
|
| [20] | Hahn HS, Yoon SG, Hong JS, Hong SR, Park SJ, et al. (2009) Conservative treatment with progestin and pregnancy outcomes in endometrial cancer. Int J Gynecol Cancer 19: 1068–1073. doi: 10.1111/IGC.0b013e3181aae1fb. pmid:19820370
|
| [21] | Ramirez PT, Frumovitz M, Bodurka DC, Sun CC, Levenback C (2004) Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review. Gynecol Oncol 95: 133–138. pmid:15385122 doi: 10.1016/j.ygyno.2004.06.045
|
| [22] | Hoekstra AV, Kim JJ, Keh P, Schink JC (2008) Absence of progesterone receptors in a failed case of fertility-sparing treatment in early endometrial cancer: a case report. J Reprod Med 53: 869–873. pmid:19097521
|
| [23] | Kim JJ, Chapman-Davis E (2010) Role of progesterone in endometrial cancer. Semin Reprod Med 28: 81–90. doi: 10.1055/s-0029-1242998. pmid:20104432
|
| [24] | Kaku T, Yoshikawa H, Tsuda H, Sakamoto A, Fukunaga M, et al. (2001) Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome. Cancer Lett 167: 39–48. pmid:11323097 doi: 10.1016/s0304-3835(01)00462-1
|
| [25] | Ness RB (2003) Endometriosis and ovarian cancer: thoughts on shared pathophysiology. Am J Obstet Gynecol 189: 280–294. pmid:12861175 doi: 10.1067/mob.2003.408
|
| [26] | Vigano P, Somigliana E, Chiodo I, Abbiati A, Vercellini P (2006) Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis. Human reproduction update 12: 77–89. pmid:16172112 doi: 10.1093/humupd/dmi037
|
| [27] | Bulun SE (2009) Endometriosis. The New England journal of medicine 360: 268–279. doi: 10.1056/NEJMra0804690. pmid:19144942
|
| [28] | Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, et al. (2010) ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 363: 1532–1543. doi: 10.1056/NEJMoa1008433. pmid:20942669
|
| [29] | Van Rechem C, Boulay G, Leprince D (2009) HIC1 interacts with a specific subunit of SWI/SNF complexes, ARID1A/BAF250A. Biochemical and biophysical research communications 385: 586–590. doi: 10.1016/j.bbrc.2009.05.115. pmid:19486893
|
| [30] | Guan B, Wang TL, Shih Ie M (2011) ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Cancer research 71: 6718–6727. doi: 10.1158/0008-5472.CAN-11-1562. pmid:21900401
|
| [31] | Jones S, Li M, Parsons DW, Zhang X, Wesseling J, et al. (2012) Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types. Human mutation 33: 100–103. doi: 10.1002/humu.21633. pmid:22009941
|
| [32] | Huang J, Zhao YL, Li Y, Fletcher JA, Xiao S (2007) Genomic and functional evidence for an ARID1A tumor suppressor role. Genes, chromosomes & cancer 46: 745–750. doi: 10.1002/gcc.20459
|
| [33] | Gao X, Tate P, Hu P, Tjian R, Skarnes WC, et al. (2008) ES cell pluripotency and germ-layer formation require the SWI/SNF chromatin remodeling component BAF250a. Proc Natl Acad Sci U S A 105: 6656–6661. doi: 10.1073/pnas.0801802105. pmid:18448678
|
| [34] | Lee JH, Kim TH, Oh SJ, Yoo JY, Akira S, et al. (2013) Signal transducer and activator of transcription-3 (Stat3) plays a critical role in implantation via progesterone receptor in uterus. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. doi: 10.1096/fj.12-225664
|
| [35] | Finn CA (1971) The biology of decidual cells. Advances in reproductive physiology 5: 1–26. pmid:4949999
|
| [36] | Jayatilak PG, Glaser LA, Warshaw ML, Herz Z, Gruber JR, et al. (1984) Relationship between luteinizing hormone and decidual luteotropin in the maintenance of luteal steroidogenesis. Biology of reproduction 31: 556–564. pmid:6487695 doi: 10.1095/biolreprod31.3.556
|
| [37] | Lala PK, Graham CH (1990) Mechanisms of trophoblast invasiveness and their control: the role of proteases and protease inhibitors. Cancer metastasis reviews 9: 369–379. pmid:2097085 doi: 10.1007/bf00049525
|
| [38] | Klemmt PA, Carver JG, Kennedy SH, Koninckx PR, Mardon HJ (2006) Stromal cells from endometriotic lesions and endometrium from women with endometriosis have reduced decidualization capacity. Fertility and sterility 85: 564–572. pmid:16500320 doi: 10.1016/j.fertnstert.2005.08.046
|
| [39] | Lee CH, Kim TH, Lee JH, Oh SJ, Yoo JY, et al. (2013) Extracellular signal-regulated kinase 1/2 signaling pathway is required for endometrial decidualization in mice and human. PLoS One 8: e75282. doi: 10.1371/journal.pone.0075282. pmid:24086495
|
| [40] | Hewitt SC, Li L, Grimm SA, Winuthayanon W, Hamilton KJ, et al. (2014) Novel DNA motif binding activity observed in vivo with an estrogen receptor alpha mutant mouse. Mol Endocrinol 28: 899–911. doi: 10.1210/me.2014-1051. pmid:24713037
|
| [41] | Ray S, Pollard JW (2012) KLF15 negatively regulates estrogen-induced epithelial cell proliferation by inhibition of DNA replication licensing. Proc Natl Acad Sci U S A 109: E1334–1343. doi: 10.1073/pnas.1118515109. pmid:22538816
|
| [42] | Jones S, Wang TL, Kurman RJ, Nakayama K, Velculescu VE, et al. (2012) Low-grade serous carcinomas of the ovary contain very few point mutations. J Pathol 226: 413–420. doi: 10.1002/path.3967. pmid:22102435
|
| [43] | Guan B, Mao TL, Panuganti PK, Kuhn E, Kurman RJ, et al. (2011) Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma. The American journal of surgical pathology 35: 625–632. doi: 10.1097/PAS.0b013e318212782a. pmid:21412130
|
| [44] | Jones S, Wang TL, Shih Ie M, Mao TL, Nakayama K, et al. (2010) Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 330: 228–231. doi: 10.1126/science.1196333. pmid:20826764
|
| [45] | Kuhn E, Wu RC, Guan B, Wu G, Zhang J, et al. (2012) Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses. Journal of the National Cancer Institute 104: 1503–1513. doi: 10.1093/jnci/djs345. pmid:22923510
|
| [46] | Kuo KT, Mao TL, Chen X, Feng Y, Nakayama K, et al. (2010) DNA copy numbers profiles in affinity-purified ovarian clear cell carcinoma. Clinical cancer research: an official journal of the American Association for Cancer Research 16: 1997–2008. doi: 10.1158/1078-0432.ccr-09-2105
|
| [47] | Wilson BG, Roberts CW (2011) SWI/SNF nucleosome remodellers and cancer. Nature reviews Cancer 11: 481–492. doi: 10.1038/nrc3068. pmid:21654818
|
| [48] | Lowery WJ, Schildkraut JM, Akushevich L, Bentley R, Marks JR, et al. (2012) Loss of ARID1A-associated protein expression is a frequent event in clear cell and endometrioid ovarian cancers. Int J Gynecol Cancer 22: 9–14. doi: 10.1097/IGC.0b013e318231f140. pmid:22193641
|
| [49] | Wang DD, Chen YB, Pan K, Wang W, Chen SP, et al. (2012) Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer. PLoS One 7: e40364. doi: 10.1371/journal.pone.0040364. pmid:22808142
|
| [50] | Samartzis EP, Noske A, Dedes KJ, Fink D, Imesch P (2013) ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas. Int J Mol Sci 14: 18824–18849. doi: 10.3390/ijms140918824. pmid:24036443
|
| [51] | Cancer Genome Atlas Research N, Kandoth C, Schultz N, Cherniack AD, Akbani R, et al. (2013) Integrated genomic characterization of endometrial carcinoma. Nature 497: 67–73. doi: 10.1038/nature12113. pmid:23636398
|
| [52] | Rahman M, Nakayama K, Rahman MT, Katagiri H, Katagiri A, et al. (2013) Clinicopathologic analysis of loss of AT-rich interactive domain 1A expression in endometrial cancer. Human pathology 44: 103–109. doi: 10.1016/j.humpath.2012.04.021. pmid:22939958
|
| [53] | Wiegand KC, Lee AF, Al-Agha OM, Chow C, Kalloger SE, et al. (2011) Loss of BAF250a (ARID1A) is frequent in high-grade endometrial carcinomas. J Pathol 224: 328–333. doi: 10.1002/path.2911. pmid:21590771
|
| [54] | Bulun SE (2009) Endometriosis. The New England journal of medicine 360: 268–279. doi: 10.1056/NEJMra0804690. pmid:19144942
|
| [55] | Soyal SM, Mukherjee A, Lee KY, Li J, Li H, et al. (2005) Cre-mediated recombination in cell lineages that express the progesterone receptor. Genesis 41: 58–66. pmid:15682389 doi: 10.1002/gene.20098
|
| [56] | Tibbetts TA, Mendoza-Meneses M, O'Malley BW, Conneely OM (1998) Mutual and intercompartmental regulation of estrogen receptor and progesterone receptor expression in the mouse uterus. Biol Reprod 59: 1143–1152. pmid:9780321 doi: 10.1095/biolreprod59.5.1143
|
| [57] | Lee K, Jeong J, Kwak I, Yu CT, Lanske B, et al. (2006) Indian hedgehog is a major mediator of progesterone signaling in the mouse uterus. Nature genetics 38: 1204–1209. pmid:16951680 doi: 10.1038/ng1874
|
| [58] | Kurihara I, Lee DK, Petit FG, Jeong J, Lee K, et al. (2007) COUP-TFII mediates progesterone regulation of uterine implantation by controlling ER activity. PLoS genetics 3: e102. pmid:17590085 doi: 10.1371/journal.pgen.0030102
|
| [59] | Braga VM, Gendler SJ (1993) Modulation of Muc-1 mucin expression in the mouse uterus during the estrus cycle, early pregnancy and placentation. Journal of cell science 105 (Pt 2): 397–405. pmid:7691839
|
| [60] | Jeong JW, Lee KY, Lydon JP, DeMayo FJ (2006) Steroid hormone regulation of Clca3 expression in the murine uterus. The Journal of endocrinology 189: 473–484. pmid:16731779 doi: 10.1677/joe.1.06747
|
| [61] | Sundstrom SA, Komm BS, Ponce-de-Leon H, Yi Z, Teuscher C, et al. (1989) Estrogen regulation of tissue-specific expression of complement C3. The Journal of biological chemistry 264: 16941–16947. pmid:2674144
|
| [62] | Surveyor GA, Gendler SJ, Pemberton L, Das SK, Chakraborty I, et al. (1995) Expression and steroid hormonal control of Muc-1 in the mouse uterus. Endocrinology 136: 3639–3647. pmid:7628404 doi: 10.1210/endo.136.8.7628404
|
| [63] | Ward PP, Mendoza-Meneses M, Mulac-Jericevic B, Cunningham GA, Saucedo-Cardenas O, et al. (1999) Restricted spatiotemporal expression of lactoferrin during murine embryonic development. Endocrinology 140: 1852–1860. pmid:10098524 doi: 10.1210/endo.140.4.6671
|
| [64] | Davis RB, Curtis CD, Griffin CT (2013) BRG1 promotes COUP-TFII expression and venous specification during embryonic vascular development. Development 140: 1272–1281. doi: 10.1242/dev.087379. pmid:23406903
|
| [65] | Franco HL, Jeong JW, Tsai SY, Lydon JP, DeMayo FJ (2008) In vivo analysis of progesterone receptor action in the uterus during embryo implantation. Semin Cell Dev Biol 19: 178–186. doi: 10.1016/j.semcdb.2007.12.001. pmid:18280760
|
| [66] | Lee KY, DeMayo FJ (2004) Animal models of implantation. Reproduction 128: 679–695. pmid:15579585 doi: 10.1530/rep.1.00340
|
| [67] | Jeong JW, Lee KY, Kwak I, White LD, Hilsenbeck SG, et al. (2005) Identification of murine uterine genes regulated in a ligand-dependent manner by the progesterone receptor. Endocrinology 146: 3490–3505. pmid:15845616 doi: 10.1210/en.2005-0016
|
| [68] | Das SK, Chakraborty I, Paria BC, Wang XN, Plowman G, et al. (1995) Amphiregulin is an implantation-specific and progesterone-regulated gene in the mouse uterus. Mol Endocrinol 9: 691–705. pmid:8592515
|
| [69] | Rubel CA, Franco HL, Jeong JW, Lydon JP, DeMayo FJ (2012) GATA2 is expressed at critical times in the mouse uterus during pregnancy. Gene expression patterns: GEP 12: 196–203. doi: 10.1016/j.gep.2012.03.004. pmid:22476030
|
| [70] | Oh SJ, Kim TH, Lim JM, Jeong JW (2013) Progesterone induces expression of Lrp2 in the murine uterus. Biochemical and biophysical research communications 441: 175–179. doi: 10.1016/j.bbrc.2013.10.037. pmid:24140060
|
| [71] | Li Q, Kannan A, DeMayo FJ, Lydon JP, Cooke PS, et al. (2011) The antiproliferative action of progesterone in uterine epithelium is mediated by Hand2. Science 331: 912–916. doi: 10.1126/science.1197454. pmid:21330545
|
| [72] | Daikoku T, Ogawa Y, Terakawa J, Ogawa A, DeFalco T, et al. (2014) Lactoferrin-iCre: a new mouse line to study uterine epithelial gene function. Endocrinology 155: 2718–2724. doi: 10.1210/en.2014-1265. pmid:24823394
|
| [73] | Contreras CM, Akbay EA, Gallardo TD, Haynie JM, Sharma S, et al. (2010) Lkb1 inactivation is sufficient to drive endometrial cancers that are aggressive yet highly responsive to mTOR inhibitor monotherapy. Disease models & mechanisms 3: 181–193. doi: 10.1242/dmm.004440
|
| [74] | Kim TH, Lee DK, Cho SN, Orvis GD, Behringer RR, et al. (2013) Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer. Cancer research 73: 5090–5099. doi: 10.1158/0008-5472.CAN-13-0241. pmid:23811943
|
| [75] | Trotter KW, Archer TK (2008) The BRG1 transcriptional coregulator. Nuclear receptor signaling 6: e004. doi: 10.1621/nrs.06004. pmid:18301784
|
| [76] | Inoue H, Giannakopoulos S, Parkhurst CN, Matsumura T, Kono EA, et al. (2011) Target genes of the largest human SWI/SNF complex subunit control cell growth. The Biochemical journal 434: 83–92. doi: 10.1042/BJ20101358. pmid:21118156
|
| [77] | Nagl NG Jr., Wang X, Patsialou A, Van Scoy M, Moran E (2007) Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. The EMBO journal 26: 752–763. pmid:17255939 doi: 10.1038/sj.emboj.7601541
|
| [78] | Nagl NG Jr., Zweitzig DR, Thimmapaya B, Beck GR Jr., Moran E (2006) The c-myc gene is a direct target of mammalian SWI/SNF-related complexes during differentiation-associated cell cycle arrest. Cancer research 66: 1289–1293. pmid:16452181 doi: 10.1158/0008-5472.can-05-3427
|
| [79] | Tangen IL, Werner HM, Berg A, Halle MK, Kusonmano K, et al. (2014) Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions. European journal of cancer 50: 3003–3010. doi: 10.1016/j.ejca.2014.09.003. pmid:25281525
|
| [80] | Wetendorf M, DeMayo FJ (2014) Progesterone receptor signaling in the initiation of pregnancy and preservation of a healthy uterus. The International journal of developmental biology 58: 95–106. doi: 10.1387/ijdb.140069mw. pmid:25023675
|
| [81] | Lessey BA, Young SL (2014) Homeostasis imbalance in the endometrium of women with implantation defects: the role of estrogen and progesterone. Semin Reprod Med 32: 365–375. doi: 10.1055/s-0034-1376355. pmid:24959818
|
| [82] | Winuthayanon W, Hewitt SC, Orvis GD, Behringer RR, Korach KS (2010) Uterine epithelial estrogen receptor alpha is dispensable for proliferation but essential for complete biological and biochemical responses. Proc Natl Acad Sci U S A 107: 19272–19277. doi: 10.1073/pnas.1013226107. pmid:20974921
|
| [83] | Pan H, Deng Y, Pollard JW (2006) Progesterone blocks estrogen-induced DNA synthesis through the inhibition of replication licensing. Proc Natl Acad Sci U S A 103: 14021–14026. pmid:16966611 doi: 10.1073/pnas.0601271103
|
| [84] | Tong W, Pollard JW (1999) Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E- and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice. Mol Cell Biol 19: 2251–2264. pmid:10022912
|
| [85] | Pan H, Zhu L, Deng Y, Pollard JW (2006) Microarray analysis of uterine epithelial gene expression during the implantation window in the mouse. Endocrinology 147: 4904–4916. pmid:16794013 doi: 10.1210/en.2006-0140
|
| [86] | Niklaus AL, Aubuchon M, Zapantis G, Li P, Qian H, et al. (2007) Assessment of the proliferative status of epithelial cell types in the endometrium of young and menopausal transition women. Human reproduction 22: 1778–1788. pmid:17371803 doi: 10.1093/humrep/dem032
|
| [87] | Suske G, Bruford E, Philipsen S (2005) Mammalian SP/KLF transcription factors: bring in the family. Genomics 85: 551–556. pmid:15820306 doi: 10.1016/j.ygeno.2005.01.005
|
| [88] | Simmen RC, Heard ME, Simmen AM, Montales MT, Marji M, et al. (2015) The Kruppel-like factors in female reproductive system pathologies. Journal of molecular endocrinology 54: R89–R101. doi: 10.1530/JME-14-0310. pmid:25654975
|
| [89] | Heard ME, Simmons CD, Simmen FA, Simmen RC (2014) Kruppel-like factor 9 deficiency in uterine endometrial cells promotes ectopic lesion establishment associated with activated notch and hedgehog signaling in a mouse model of endometriosis. Endocrinology 155: 1532–1546. doi: 10.1210/en.2013-1947. pmid:24476135
|
| [90] | Pabona JM, Simmen FA, Nikiforov MA, Zhuang D, Shankar K, et al. (2012) Kruppel-like factor 9 and progesterone receptor coregulation of decidualizing endometrial stromal cells: implications for the pathogenesis of endometriosis. The Journal of clinical endocrinology and metabolism 97: E376–392. doi: 10.1210/jc.2011-2562. pmid:22259059
|
| [91] | Velarde MC, Geng Y, Eason RR, Simmen FA, Simmen RC (2005) Null mutation of Kruppel-like factor9/basic transcription element binding protein-1 alters peri-implantation uterine development in mice. Biology of reproduction 73: 472–481. pmid:15917344
|
| [92] | Lee KY, Jeong JW, Wang J, Ma L, Martin JF, et al. (2007) Bmp2 is critical for the murine uterine decidual response. Mol Cell Biol 27: 5468–5478. pmid:17515606 doi: 10.1128/mcb.00342-07
|
| [93] | Yang Z, Wolf IM, Chen H, Periyasamy S, Chen Z, et al. (2006) FK506-binding protein 52 is essential to uterine reproductive physiology controlled by the progesterone receptor A isoform. Molecular endocrinology 20: 2682–2694. pmid:16873445 doi: 10.1210/me.2006-0024
|
| [94] | Tranguch S, Cheung-Flynn J, Daikoku T, Prapapanich V, Cox MB, et al. (2005) Cochaperone immunophilin FKBP52 is critical to uterine receptivity for embryo implantation. Proc Natl Acad Sci U S A 102: 14326–14331. pmid:16176985 doi: 10.1073/pnas.0505775102
|
| [95] | Kearns AE, Demay MB (2000) BMP-2 induces the expression of activin betaA and follistatin in vitro. Journal of cellular biochemistry 79: 80–88. pmid:10906757
|
| [96] | Korhonen MO, Symons JP, Hyde BM, Rowan JP, Wilborn WH (1997) Histologic classification and pathologic findings for endometrial biopsy specimens obtained from 2964 perimenopausal and postmenopausal women undergoing screening for continuous hormones as replacement therapy (CHART 2 Study). American journal of obstetrics and gynecology 176: 377–380. pmid:9065185 doi: 10.1016/s0002-9378(97)70502-7
|
| [97] | Kim BG, Yoo JY, Kim TH, Shin JH, Langenheim JF, et al. (2015) Aberrant activation of signal transducer and activator of transcription-3 (STAT3) signaling in endometriosis. Hum Reprod 30: 1069–1078. doi: 10.1093/humrep/dev050. pmid:25750101
|
| [98] | Yoo JY, Shin H, Kim TH, Choi WS, Ferguson SD, et al. (2014) CRISPLD2 is a target of progesterone receptor and its expression is decreased in women with endometriosis. PloS one 9: e100481. doi: 10.1371/journal.pone.0100481. pmid:24955763
|
| [99] | Noyes RW, Hertig AT, Rock J (1975) Dating the endometrial biopsy. Am J Obstet Gynecol 122: 262–263. pmid:1155504
|
| [100] | Finn CA, Martin L (1972) Endocrine control of the timing of endometrial sensitivity to a decidual stimulus. Biology of reproduction 7: 82–86. pmid:5050152
|
| [101] | Ishibashi H, Suzuki T, Suzuki S, Moriya T, Kaneko C, et al. (2003) Sex steroid hormone receptors in human thymoma. The Journal of clinical endocrinology and metabolism 88: 2309–2317. pmid:12727990 doi: 10.1210/jc.2002-021353
|
| [102] | Mazur EC, Vasquez YM, Li X, Kommagani R, Jiang L, et al. (2015) Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells. Endocrinology 156: 2239–2253. doi: 10.1210/en.2014-1566. pmid:25781565
|
| [103] | Kim TH, Yoo JY, Kim HI, Gilbert J, Ku BJ, et al. (2014) Mig-6 suppresses endometrial cancer associated with Pten deficiency and ERK activation. Cancer Res 74: 7371–7382. doi: 10.1158/0008-5472.CAN-14-0794. pmid:25377472
|
